The new branding initiative was combined with a Marketing with Meaning campaign to support the German Children Cancer Foundation.
Berlin - 30 November 2015 – KCR, international Contract Research Organization (CRO), announced its new branding of services during the Partnership in Clinical Trials (PCT) Congress in Hamburg, Germany, on 18th November 2015. The new branding initiative was combined with a Marketing with Meaning campaign to support the German Children Cancer Foundation.
KCR’s new visual identity enhances the company’s transparency and integrity. Three core services provided by the CRO - Trial Execution (TE), Functional Service Provision (FSP) and Late Phase (LP) - have been branded in new colors: pink, blue and green respectively.
“In today’s contract research world with rising complexity and constantly new demands we all seek clear and comprehensible information about services and their successful delivery,” said Mike Jagielski, President & CEO of KCR. “I believe that our new branding reflects the company development and customer-focused approach.”
KCR has undergone a tremendous transformation over the last couple of years: from a regional service provider to an internationally operating CRO. “We envision ourselves as a knowledge and clinical operations service provider. Our emphasis lies on knowledge as it allows us to define smart operation execution strategies for our clients to successfully work on more and more complex projects,” continued Mr. Jagielski.
“Nevertheless, knowledge and operations need a structure and that is why we decided to continue our future development with a distinct service branding as it is the best way of demonstrating our services and capability portfolio,” he added.
KCR presented its new branding at PCT 2015, one of the biggest industry events. About 300 copies of the company newspaper, KCR Times, which had been prepared especially for the Hamburg event and included a particular sticker, were distributed at the venue. Handing in the sticker at the company stand meant a KCR 10 EUR donation to the German Children Cancer Foundation.
“We are very happy that PCT participants widely engaged in our promotion and came to our booth to support the charity campaign. We believe that the only successful marketing is this one with meaning about improving other lives,” summarized Mr. Jagielski.
KCR is a Contract Research Organization (CRO) operating across 19 countries in Europe as well as the U.S. The company is a strategic solutions provider for pharmaceutical and biotechnology firms who are looking for a reliable alternative to top tier CROs. Over 300 professionals offer full service capabilities in three main product lines: Trial Execution, Functional Service Provision (FSP) and Late Phase, across a wide range of therapeutic areas. Focusing on knowledge, quality and innovation, KCR and its services supports 12 of the Top 20 Global Pharma companies, as well as biotech firms from Europe, Israel and the U.S. on long standing contracts. For more information please visit: www.kcrcro.com.
KCR: We see human behind every number
Associate Director, PR & Marketing
mobile: (+48) 605 053 164